Series A round brings $38mm to Caballeta Bio

15:40 EDT 28 Oct 2019 | Elsevier Business Intelligence

Caballeta Bio Inc. raised $38mm through its Series A round led by 5AM Ventures. Founding investors Adage Capital Management a...

Original Article: Series A round brings $38mm to Caballeta Bio


More From BioPortfolio on "Series A round brings $38mm to Caballeta Bio"

Quick Search

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...